Ready-to-use 3D Cell Cultures for early de-risking in drug development

Project Information

3DCC

Grant agreement ID: 745220

DOI 10.3030/745220

Closed project

EC signature date 7 December 2016

Start date 1 December 2016

End date 30 April 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

STEMTEK THERAPEUTICS SL
Spain